A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 1, 2015-07 ,pp. : 115-127

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vitality, Perceived Social Support and Disease Activity Determine the Performance of Social Roles in Recently Diagnosed Multiple Sclerosis: A Longitudinal Analysis

By de Groot Vincent   Beckerman Heleen   Twisk Jos W.   Uitdehaag Bernard M.   Hintzen Rogier Q.   Minneboo Arjan   Lankhorst Gustaaf J.   Polman Chris H.   Bouter Lex M.  

Journal of Rehabilitation Medicine, Vol. 40, Iss. 2, 2008-02 ,pp. : 151-157

Medical Journals Limited

Access to resources Recommend Favorite

Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design

By Cascione Mark  

Journal of Medical Economics, Vol. 16, Iss. 7, 2013-07 ,pp. : 859-865

Informa Healthcare

Access to resources Recommend Favorite

Exploring physical activity behaviour of persons with multiple sclerosis: a qualitative pilot study

By Plow Matthew   Resnik Linda   Allen Susan  

Disability and Rehabilitation, Vol. 31, Iss. 20, 2009-09 ,pp. : 1652-1665

Informa Healthcare

Access to resources Recommend Favorite

Natalizumab improves ambulation in relapsing−remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 3, 2015-03 ,pp. : 570-577

John Wiley & Sons Inc

Access to resources Recommend Favorite